Malgorzata Dawidowska

Poznan, WP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Journal: Haematologica

Published: June 30, 2026

Systematic profiling of AGO2-associated circRNAs and functional investigation reveal circN4BP2L2 as a survival-promoting regulator in T-ALL.

Systematic profiling of AGO2-associated circRNAs and functional investigation reveal circN4BP2L2 as a survival-promoting regulator in T-ALL.

Journal: Leukemia

Published: December 01, 2025

Genetic alterations in lymphoblastic leukaemia / lymphoma - a practical guide to WHO HAEM5.

Genetic alterations in lymphoblastic leukaemia / lymphoma - a practical guide to WHO HAEM5.

Journal: Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V

Published: June 05, 2024

Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia.

Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia.

Journal: Blood

Published: February 14, 2024

Small RNA-Seq Reveals Similar miRNA Transcriptome in Children and Young Adults with T-ALL and Indicates miR-143-3p as Novel Candidate Tumor Suppressor in This Leukemia.

Small RNA-Seq Reveals Similar miRNA Transcriptome in Children and Young Adults with T-ALL and Indicates miR-143-3p as Novel Candidate Tumor Suppressor in This Leukemia.

Journal: International journal of molecular sciences

Published: July 15, 2022

Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: Focus on miR-363-3p and promoter methylation.

Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: Focus on miR-363-3p and promoter methylation.

Journal: Genes, chromosomes & cancer

Published: March 04, 2022

CRISPRi for specific inhibition of miRNA clusters and miRNAs with high sequence homology.

CRISPRi for specific inhibition of miRNA clusters and miRNAs with high sequence homology.

Journal: Scientific reports

Published: November 26, 2021

RNA-seq library preparation for comprehensive transcriptome analysis in cancer cells: The impact of insert size.

RNA-seq library preparation for comprehensive transcriptome analysis in cancer cells: The impact of insert size.

Journal: Genomics

Published: May 19, 2021

DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning.

DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning.

Journal: International journal of molecular sciences

Published: December 24, 2020

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.

Journal: Blood cancer discovery

Published: November 12, 2020

hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of PTEN and BIM Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro.

hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of PTEN and BIM Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro.

Journal: Cells

Published: March 15, 2020

PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols.

PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols.

Journal: American journal of hematology

Published: December 22, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026